Nu-Med Plus, Inc. announces trading on OTCQB Marketplace

Nu-Med Plus (OTCBB:NUMD), a medical device development company announced it has begun to have its securities designated and traded as OTCQB securities which will be subject to QTCB Standards.
As quoted in the press release:

Jeff Robins, President and CEO of Nu-Med Plus, Inc. commented, “We are very excited about the opportunity to trade our securities on the QTQB platform which will allow Nu-Med to distribute its information and bring transparency to a wide audience of U.S. investors, market data distributors, investment databases, media outlets, and broker-dealers, while allowing our investors to propel our vision forward turning our Medical Devices into technological reality.”

Click here to read the full press release.